- Title: Prostate cancer drugs could pose risk to heart health: FDA reviewing safety of anti-hormone treatments due to links with heart disease and diabetes.(MEDICAL THERAPY): An article from: Heart Advisor
- Author: Unavailable
- Released: 0000-00-00
- Pages: 0
- ASIN: B003ZCQUK4
The Food and Drug Administration (FDA) has announced that it is investigating the safety of gonadotropin-releasing hormone (GnRH) agonists, a class of drugs used to treat prostate cancer, after evidence linking them with a rise in the risk of heart disease and diabetes.
It's not the first time concerns have been raised about the use of hormone therapy to treat prostate cancer--a 2009 study suggested it raises the risk of heart disease by as much as 25 percent, while other research suggests it may double the risk of metabolic syndrome, a cluster of risk factors linked to the development of heart disease, as well as cause declines in bone density.pdf